143 related articles for article (PubMed ID: 31415427)
1. Predictors of quality of care and survival in a three-state cohort of locally advanced cervical cancer patients and development of a predictive model to identify women at risk of incomplete treatment.
Schad MD; Moore J; Camacho F; Anderson RT; Cantrell LA; Showalter TN
Medicine (Baltimore); 2019 Aug; 98(33):e16874. PubMed ID: 31415427
[TBL] [Abstract][Full Text] [Related]
2. Determinants of Quality Care and Mortality for Patients With Locally Advanced Cervical Cancer in Virginia.
Showalter TN; Camacho F; Cantrell LA; Anderson RT
Medicine (Baltimore); 2016 Feb; 95(8):e2913. PubMed ID: 26937934
[TBL] [Abstract][Full Text] [Related]
3. Impact of marital status on receipt of brachytherapy and survival outcomes in locally advanced cervical cancer.
Huynh-Le MP; Klapheke A; Cress R; Mell LK; Yashar CM; Einck JP; Mundt AJ; Mayadev JS
Brachytherapy; 2019; 18(5):612-619. PubMed ID: 31153760
[TBL] [Abstract][Full Text] [Related]
4. Racial disparities in brachytherapy administration and survival in women with locally advanced cervical cancer.
Alimena S; Yang DD; Melamed A; Mahal BA; Worley MJ; Feldman S; Elias KM; Orio PF; Lee LJ; King M
Gynecol Oncol; 2019 Sep; 154(3):595-601. PubMed ID: 31292103
[TBL] [Abstract][Full Text] [Related]
5. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
[TBL] [Abstract][Full Text] [Related]
6. Identifying disparities in brachytherapy delivery for locally advanced cervical cancer.
Eakin A; Wairiri L; Stadtlander W; Bruegl A; Emerson J; Williamson C; Kahn J
Brachytherapy; 2023; 22(4):461-467. PubMed ID: 37015846
[TBL] [Abstract][Full Text] [Related]
7. Better late than never: Brachytherapy is more important than timing in treatment of locally advanced cervical cancer.
Korenaga TK; Yoshida EJ; Pierson W; Chang J; Ziogas A; Swanson ML; Chapman JS; Sinha S; Chen LM
Gynecol Oncol; 2022 Feb; 164(2):348-356. PubMed ID: 34865860
[TBL] [Abstract][Full Text] [Related]
8. Brachytherapy Improves Survival in Stage III Endometrial Cancer With Cervical Involvement.
Bingham B; Orton A; Boothe D; Stoddard G; Huang YJ; Gaffney DK; Poppe MM
Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):1040-1050. PubMed ID: 28332987
[TBL] [Abstract][Full Text] [Related]
9. Underutilization of brachytherapy and disparities in survival for patients with cervical cancer in California.
Mayadev J; Klapheke A; Yashar C; Hsu IC; Kamrava M; Mundt AJ; Mell LK; Einck J; Benedict S; Valicenti R; Cress R
Gynecol Oncol; 2018 Jul; 150(1):73-78. PubMed ID: 29709291
[TBL] [Abstract][Full Text] [Related]
10. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
Kokka F; Bryant A; Brockbank E; Powell M; Oram D
Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
[TBL] [Abstract][Full Text] [Related]
11. Disparities Among Cervical Cancer Patients Receiving Brachytherapy.
Bruce SF; Joshi TV; Chervoneva I; Yi M; Chatterjee-Paer S; Burton ER; Edelson MI; Sorosky JI; Shahin MS
Obstet Gynecol; 2019 Sep; 134(3):559-569. PubMed ID: 31403593
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the urban-rural paradox: The complicated relationship between distance and the receipt of guideline-concordant care among cervical cancer patients.
Spees LP; Wheeler SB; Varia M; Weinberger M; Baggett CD; Zhou X; Petermann VM; Brewster WR
Gynecol Oncol; 2019 Jan; 152(1):112-118. PubMed ID: 30442384
[TBL] [Abstract][Full Text] [Related]
13. Updated Trends in the Utilization of Brachytherapy in Cervical Cancer in the United States: A Surveillance, Epidemiology, and End-Results Study.
Han K; Colson-Fearon D; Liu ZA; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2024 May; 119(1):143-153. PubMed ID: 37951548
[TBL] [Abstract][Full Text] [Related]
14. Examining Urban and Rural Differences in How Distance to Care Influences the Initiation and Completion of Treatment among Insured Cervical Cancer Patients.
Spees LP; Brewster WR; Varia MA; Weinberger M; Baggett C; Zhou X; Petermann VM; Wheeler SB
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):882-889. PubMed ID: 30733307
[TBL] [Abstract][Full Text] [Related]
15. Impact of facility volume on therapy and survival for locally advanced cervical cancer.
Lin JF; Berger JL; Krivak TC; Beriwal S; Chan JK; Sukumvanich P; Monk BJ; Richard SD
Gynecol Oncol; 2014 Feb; 132(2):416-22. PubMed ID: 24333361
[TBL] [Abstract][Full Text] [Related]
16. Survival Benefit of Adjuvant Brachytherapy After Hysterectomy With Positive Surgical Margins in Cervical Cancer.
Li R; Shinde A; Chen YJ; Amini A; Lee S; Dellinger T; Han E; Wakabayashi M; Nelson R; Beriwal S; Glaser S
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):373-382. PubMed ID: 29890264
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer care in rural Virginia: The impact of distance from an academic medical center on outcomes & the role of non-specialized radiation centers.
Rauh LA; Saks EJ; Nakad-Rodriguez D; Showalter TN; Duska LR
Gynecol Oncol; 2018 Aug; 150(2):338-342. PubMed ID: 29935911
[TBL] [Abstract][Full Text] [Related]
18. Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.
Brodeur MN; Dejean R; Beauchemin MC; Samouëlian V; Cormier B; Bacha OM; Warkus T; Barkati M
Gynecol Oncol; 2021 Aug; 162(2):277-283. PubMed ID: 34059350
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging after external beam radiotherapy and concurrent chemotherapy for locally advanced cervical cancer helps to identify patients at risk of recurrence.
Angeles MA; Baissas P; Leblanc E; Lusque A; Ferron G; Ducassou A; Martínez-Gómez C; Querleu D; Martinez A
Int J Gynecol Cancer; 2019 Mar; 29(3):480-486. PubMed ID: 30712019
[TBL] [Abstract][Full Text] [Related]
20. Primary treatment patterns and survival of cervical cancer in Sweden: A population-based Swedish Gynecologic Cancer Group Study.
Bjurberg M; Holmberg E; Borgfeldt C; Flöter-Rådestad A; Dahm-Kähler P; Hjerpe E; Högberg T; Kjølhede P; Marcickiewicz J; Rosenberg P; Stålberg K; Tholander B; Hellman K; Åvall-Lundqvist E
Gynecol Oncol; 2019 Nov; 155(2):229-236. PubMed ID: 31477283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
